COMP <GO>
ADUS vs MRK // REVENUE GROWTH (YOY)
Addus HomeCare Corporation (NASDAQ) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: ADUS 5
— MRK 8
▲ REVENUE GROWTH (YOY) LEADER: ADUS
LAST: $124.34 (+1.77%) • MKT CAP: $2.32B
revenue-growth
23.20%
LAST: $146.33 (+3.83%) • MKT CAP: $361.02B
revenue-growth
1.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ADUS VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ADUS | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 32.50% | 74.80% | -42.30 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.10% | 20.70% | -11.60 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | 16.8x | 15.3x | +1.50 | MRK | /valuation <GO> |
| Free Cash Flow Yield | 4.47% | 3.42% | +1.05 | ADUS | /fcf-yield <GO> |
| Operating Margin | 9.70% | 34.30% | -24.60 | MRK | /operating-margins <GO> |
| Net Profit Margin | 6.70% | 28.10% | -21.40 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 23.20% | 1.30% | +21.90 | ADUS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.83 | 5.19 | +0.64 | ADUS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 7/9 | +2.00 | ADUS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 67.8 | 51.7 | +16.10 | ADUS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.92 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 20.3x | 18.4x | +1.90 | MRK | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.32B | $361.02B | -$358.70B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ADUS REV | MRK REV | ADUS GROSS % | MRK GROSS % | ADUS FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.42B | $65.01B | 32.5% | 74.8% | $103.8M | $12.36B |
| FY 2024 | $1.15B | $64.17B | 32.5% | 76.3% | $110.4M | $18.10B |
| FY 2023 | $1.06B | $60.12B | — | — | $112.2M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ADUS // BETA —
MRK // BETA 0.92